nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrosine—TH—p38 signaling mediated by MAPKAP kinases—LSP1—urinary bladder cancer	0.123	0.273	CbGpPWpGaD
Metyrosine—Hypervigilance—Methotrexate—urinary bladder cancer	0.0435	0.0866	CcSEcCtD
Metyrosine—TH—Dopamine metabolism—NQO1—urinary bladder cancer	0.043	0.0954	CbGpPWpGaD
Metyrosine—TH—Dopaminergic Neurogenesis—GLI1—urinary bladder cancer	0.0378	0.0839	CbGpPWpGaD
Metyrosine—Speech impairment NOS—Fluorouracil—urinary bladder cancer	0.0276	0.0549	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—MT2A—urinary bladder cancer	0.0215	0.0478	CbGpPWpGaD
Metyrosine—Acetaminophen—TRPV1—urinary bladder cancer	0.0156	0.333	CrCbGaD
Metyrosine—TH—Amino acid and derivative metabolism—GSTZ1—urinary bladder cancer	0.0152	0.0336	CbGpPWpGaD
Metyrosine—TH—Parkinsons Disease Pathway—CCNE1—urinary bladder cancer	0.0144	0.0319	CbGpPWpGaD
Metyrosine—Speech impairment NOS—Methotrexate—urinary bladder cancer	0.0144	0.0286	CcSEcCtD
Metyrosine—Parkinsonism—Fluorouracil—urinary bladder cancer	0.0133	0.0264	CcSEcCtD
Metyrosine—Acetaminophen—NAT2—urinary bladder cancer	0.0123	0.263	CrCbGaD
Metyrosine—Dysuria—Valrubicin—urinary bladder cancer	0.0123	0.0246	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.0116	0.0257	CbGpPWpGaD
Metyrosine—Haematuria—Valrubicin—urinary bladder cancer	0.0112	0.0223	CcSEcCtD
Metyrosine—Oedema peripheral—Valrubicin—urinary bladder cancer	0.0104	0.0207	CcSEcCtD
Metyrosine—Thrombocytosis—Gemcitabine—urinary bladder cancer	0.00985	0.0196	CcSEcCtD
Metyrosine—Extrapyramidal disorder—Thiotepa—urinary bladder cancer	0.00967	0.0193	CcSEcCtD
Metyrosine—Anaemia—Valrubicin—urinary bladder cancer	0.00849	0.0169	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—PLAU—urinary bladder cancer	0.00821	0.0182	CbGpPWpGaD
Metyrosine—Ibuprofen—UGT2B7—urinary bladder cancer	0.00789	0.168	CrCbGaD
Metyrosine—TH—ATF-2 transcription factor network—CDK4—urinary bladder cancer	0.00776	0.0172	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—ESR1—urinary bladder cancer	0.00772	0.0171	CbGpPWpGaD
Metyrosine—TH—Alpha-synuclein signaling—SRC—urinary bladder cancer	0.0075	0.0166	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.00716	0.0159	CbGpPWpGaD
Metyrosine—Speech disorder—Fluorouracil—urinary bladder cancer	0.007	0.0139	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—RB1—urinary bladder cancer	0.00674	0.015	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—ESR1—urinary bladder cancer	0.00674	0.0149	CbGpPWpGaD
Metyrosine—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00618	0.0123	CcSEcCtD
Metyrosine—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00613	0.0122	CcSEcCtD
Metyrosine—TH—Monoamine Transport—TNF—urinary bladder cancer	0.00611	0.0135	CbGpPWpGaD
Metyrosine—Abdominal pain—Valrubicin—urinary bladder cancer	0.00593	0.0118	CcSEcCtD
Metyrosine—Anaemia—Mitomycin—urinary bladder cancer	0.00585	0.0116	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.00585	0.013	CbGpPWpGaD
Metyrosine—Asthenia—Valrubicin—urinary bladder cancer	0.00538	0.0107	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—CXCL8—urinary bladder cancer	0.00538	0.0119	CbGpPWpGaD
Metyrosine—Confusional state—Mitomycin—urinary bladder cancer	0.00521	0.0104	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.00517	0.0115	CbGpPWpGaD
Metyrosine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00513	0.0102	CcSEcCtD
Metyrosine—TH—Amino acid and derivative metabolism—NQO1—urinary bladder cancer	0.00508	0.0113	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00506	0.0101	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—CCND1—urinary bladder cancer	0.00501	0.0111	CbGpPWpGaD
Metyrosine—Swelling—Fluorouracil—urinary bladder cancer	0.00496	0.00987	CcSEcCtD
Metyrosine—Disorientation—Fluorouracil—urinary bladder cancer	0.00489	0.00973	CcSEcCtD
Metyrosine—Vomiting—Valrubicin—urinary bladder cancer	0.00477	0.00949	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Thiotepa—urinary bladder cancer	0.00476	0.00948	CcSEcCtD
Metyrosine—Thrombocytosis—Epirubicin—urinary bladder cancer	0.00472	0.00939	CcSEcCtD
Metyrosine—Headache—Valrubicin—urinary bladder cancer	0.0047	0.00935	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.00469	0.0104	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—EP300—urinary bladder cancer	0.00461	0.0102	CbGpPWpGaD
Metyrosine—Nasal congestion—Cisplatin—urinary bladder cancer	0.00455	0.00906	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—IL2—urinary bladder cancer	0.00448	0.00994	CbGpPWpGaD
Metyrosine—Ibuprofen—CXCL8—urinary bladder cancer	0.00446	0.0951	CrCbGaD
Metyrosine—Nausea—Valrubicin—urinary bladder cancer	0.00446	0.00887	CcSEcCtD
Metyrosine—Fatigue—Mitomycin—urinary bladder cancer	0.00446	0.00887	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.00437	0.00969	CbGpPWpGaD
Metyrosine—Thrombocytosis—Doxorubicin—urinary bladder cancer	0.00436	0.00869	CcSEcCtD
Metyrosine—Swelling—Etoposide—urinary bladder cancer	0.00431	0.00857	CcSEcCtD
Metyrosine—Dysuria—Thiotepa—urinary bladder cancer	0.00427	0.00851	CcSEcCtD
Metyrosine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00426	0.00848	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.00424	0.00941	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.00422	0.00935	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—EP300—urinary bladder cancer	0.00402	0.00892	CbGpPWpGaD
Metyrosine—Aspartate aminotransferase increased—Gemcitabine—urinary bladder cancer	0.00401	0.00797	CcSEcCtD
Metyrosine—Haematuria—Thiotepa—urinary bladder cancer	0.00388	0.00773	CcSEcCtD
Metyrosine—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00374	0.00745	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Cisplatin—urinary bladder cancer	0.00373	0.00743	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—TYMS—urinary bladder cancer	0.00373	0.00828	CbGpPWpGaD
Metyrosine—Asthenia—Mitomycin—urinary bladder cancer	0.00371	0.00738	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.00369	0.00818	CbGpPWpGaD
Metyrosine—Speech disorder—Methotrexate—urinary bladder cancer	0.00364	0.00725	CcSEcCtD
Metyrosine—Hallucination—Thiotepa—urinary bladder cancer	0.00364	0.00725	CcSEcCtD
Metyrosine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00354	0.00704	CcSEcCtD
Metyrosine—Blood disorder—Epirubicin—urinary bladder cancer	0.00351	0.00699	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—MYC—urinary bladder cancer	0.0035	0.00777	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—FAS—urinary bladder cancer	0.00331	0.00733	CbGpPWpGaD
Metyrosine—Vomiting—Mitomycin—urinary bladder cancer	0.00329	0.00654	CcSEcCtD
Metyrosine—Haematuria—Gemcitabine—urinary bladder cancer	0.00327	0.00651	CcSEcCtD
Metyrosine—Blood disorder—Doxorubicin—urinary bladder cancer	0.00325	0.00647	CcSEcCtD
Metyrosine—Headache—Mitomycin—urinary bladder cancer	0.00324	0.00644	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.00311	0.0069	CbGpPWpGaD
Metyrosine—Ibuprofen—PPARG—urinary bladder cancer	0.00308	0.0657	CrCbGaD
Metyrosine—Nausea—Mitomycin—urinary bladder cancer	0.00307	0.00611	CcSEcCtD
Metyrosine—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.00303	0.00603	CcSEcCtD
Metyrosine—Anaemia—Thiotepa—urinary bladder cancer	0.00294	0.00586	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—CDK4—urinary bladder cancer	0.00291	0.00645	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—TP53—urinary bladder cancer	0.00288	0.00638	CbGpPWpGaD
Metyrosine—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.00285	0.00567	CcSEcCtD
Metyrosine—TH—Metabolism—GSTZ1—urinary bladder cancer	0.00279	0.00618	CbGpPWpGaD
Metyrosine—Anxiety—Thiotepa—urinary bladder cancer	0.0027	0.00538	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—PPARG—urinary bladder cancer	0.00264	0.00586	CbGpPWpGaD
Metyrosine—TH—Metabolism—GSTO2—urinary bladder cancer	0.00264	0.00586	CbGpPWpGaD
Metyrosine—TH—Metabolism—NAT1—urinary bladder cancer	0.00264	0.00586	CbGpPWpGaD
Metyrosine—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.00264	0.00525	CcSEcCtD
Metyrosine—Confusional state—Thiotepa—urinary bladder cancer	0.00262	0.00522	CcSEcCtD
Metyrosine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00254	0.00507	CcSEcCtD
Metyrosine—Anaemia—Gemcitabine—urinary bladder cancer	0.00248	0.00493	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.00247	0.00548	CbGpPWpGaD
Metyrosine—Anaemia—Fluorouracil—urinary bladder cancer	0.00243	0.00485	CcSEcCtD
Metyrosine—TH—Metabolism—UGT2B7—urinary bladder cancer	0.00241	0.00536	CbGpPWpGaD
Metyrosine—Tremor—Cisplatin—urinary bladder cancer	0.00234	0.00466	CcSEcCtD
Metyrosine—Anaemia—Cisplatin—urinary bladder cancer	0.00231	0.00459	CcSEcCtD
Metyrosine—Fatigue—Thiotepa—urinary bladder cancer	0.00224	0.00446	CcSEcCtD
Metyrosine—Acetaminophen—PTGS2—urinary bladder cancer	0.00219	0.0467	CrCbGaD
Metyrosine—TH—Metabolism—CYP4B1—urinary bladder cancer	0.00217	0.00482	CbGpPWpGaD
Metyrosine—Confusional state—Fluorouracil—urinary bladder cancer	0.00217	0.00431	CcSEcCtD
Metyrosine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00214	0.00426	CcSEcCtD
Metyrosine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00214	0.00426	CcSEcCtD
Metyrosine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00212	0.00423	CcSEcCtD
Metyrosine—Anxiety—Cisplatin—urinary bladder cancer	0.00212	0.00422	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.00212	0.0047	CbGpPWpGaD
Metyrosine—Anaemia—Etoposide—urinary bladder cancer	0.00211	0.00421	CcSEcCtD
Metyrosine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.0021	0.00419	CcSEcCtD
Metyrosine—Urticaria—Thiotepa—urinary bladder cancer	0.00206	0.00411	CcSEcCtD
Metyrosine—Abdominal pain—Thiotepa—urinary bladder cancer	0.00205	0.00409	CcSEcCtD
Metyrosine—TH—Metabolism—SLC19A1—urinary bladder cancer	0.00205	0.00455	CbGpPWpGaD
Metyrosine—TH—Metabolism—PRSS3—urinary bladder cancer	0.002	0.00444	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00199	0.00397	CcSEcCtD
Metyrosine—Insomnia—Gemcitabine—urinary bladder cancer	0.00198	0.00394	CcSEcCtD
Metyrosine—Eosinophilia—Methotrexate—urinary bladder cancer	0.00195	0.00388	CcSEcCtD
Metyrosine—Insomnia—Fluorouracil—urinary bladder cancer	0.00194	0.00387	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.00192	0.00382	CcSEcCtD
Metyrosine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00191	0.00381	CcSEcCtD
Metyrosine—Fatigue—Gemcitabine—urinary bladder cancer	0.00188	0.00375	CcSEcCtD
Metyrosine—Confusional state—Etoposide—urinary bladder cancer	0.00188	0.00375	CcSEcCtD
Metyrosine—Asthenia—Thiotepa—urinary bladder cancer	0.00186	0.00371	CcSEcCtD
Metyrosine—Dysuria—Methotrexate—urinary bladder cancer	0.00184	0.00366	CcSEcCtD
Metyrosine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00183	0.00364	CcSEcCtD
Metyrosine—Eosinophilia—Epirubicin—urinary bladder cancer	0.00182	0.00363	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—PTEN—urinary bladder cancer	0.00181	0.00402	CbGpPWpGaD
Metyrosine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00181	0.0036	CcSEcCtD
Metyrosine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.0018	0.00359	CcSEcCtD
Metyrosine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00178	0.00354	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00177	0.00353	CcSEcCtD
Metyrosine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00177	0.00353	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—EP300—urinary bladder cancer	0.00173	0.00384	CbGpPWpGaD
Metyrosine—Dysuria—Epirubicin—urinary bladder cancer	0.00172	0.00343	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.00172	0.00381	CbGpPWpGaD
Metyrosine—Urticaria—Fluorouracil—urinary bladder cancer	0.00171	0.0034	CcSEcCtD
Metyrosine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00169	0.00336	CcSEcCtD
Metyrosine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00168	0.00334	CcSEcCtD
Metyrosine—Haematuria—Methotrexate—urinary bladder cancer	0.00167	0.00333	CcSEcCtD
Metyrosine—Vomiting—Thiotepa—urinary bladder cancer	0.00165	0.00329	CcSEcCtD
Metyrosine—Headache—Thiotepa—urinary bladder cancer	0.00163	0.00324	CcSEcCtD
Metyrosine—Fatigue—Etoposide—urinary bladder cancer	0.00161	0.0032	CcSEcCtD
Metyrosine—TH—Metabolism—TYMP—urinary bladder cancer	0.0016	0.00355	CbGpPWpGaD
Metyrosine—Dysuria—Doxorubicin—urinary bladder cancer	0.00159	0.00317	CcSEcCtD
Metyrosine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00158	0.00315	CcSEcCtD
Metyrosine—Asthenia—Gemcitabine—urinary bladder cancer	0.00157	0.00312	CcSEcCtD
Metyrosine—Haematuria—Epirubicin—urinary bladder cancer	0.00156	0.00311	CcSEcCtD
Metyrosine—Nausea—Thiotepa—urinary bladder cancer	0.00154	0.00307	CcSEcCtD
Metyrosine—Feeling abnormal—Etoposide—urinary bladder cancer	0.00154	0.00306	CcSEcCtD
Metyrosine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00153	0.00304	CcSEcCtD
Metyrosine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.0015	0.00299	CcSEcCtD
Metyrosine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.0015	0.00298	CcSEcCtD
Metyrosine—Urticaria—Etoposide—urinary bladder cancer	0.00148	0.00295	CcSEcCtD
Metyrosine—Abdominal pain—Etoposide—urinary bladder cancer	0.00148	0.00294	CcSEcCtD
Metyrosine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00147	0.00293	CcSEcCtD
Metyrosine—Asthenia—Cisplatin—urinary bladder cancer	0.00146	0.00291	CcSEcCtD
Metyrosine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00145	0.00289	CcSEcCtD
Metyrosine—Haematuria—Doxorubicin—urinary bladder cancer	0.00145	0.00288	CcSEcCtD
Metyrosine—TH—Metabolism—NAT2—urinary bladder cancer	0.00145	0.00321	CbGpPWpGaD
Metyrosine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00139	0.00278	CcSEcCtD
Metyrosine—Vomiting—Gemcitabine—urinary bladder cancer	0.00139	0.00277	CcSEcCtD
Metyrosine—Hypersensitivity—Etoposide—urinary bladder cancer	0.00138	0.00274	CcSEcCtD
Metyrosine—Headache—Gemcitabine—urinary bladder cancer	0.00137	0.00273	CcSEcCtD
Metyrosine—Vomiting—Fluorouracil—urinary bladder cancer	0.00137	0.00272	CcSEcCtD
Metyrosine—Headache—Fluorouracil—urinary bladder cancer	0.00135	0.00268	CcSEcCtD
Metyrosine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00134	0.00267	CcSEcCtD
Metyrosine—Asthenia—Etoposide—urinary bladder cancer	0.00134	0.00267	CcSEcCtD
Metyrosine—Ibuprofen—PTGS2—urinary bladder cancer	0.0013	0.0277	CrCbGaD
Metyrosine—Nausea—Gemcitabine—urinary bladder cancer	0.0013	0.00258	CcSEcCtD
Metyrosine—Vomiting—Cisplatin—urinary bladder cancer	0.0013	0.00258	CcSEcCtD
Metyrosine—Diarrhoea—Etoposide—urinary bladder cancer	0.00128	0.00254	CcSEcCtD
Metyrosine—Nausea—Fluorouracil—urinary bladder cancer	0.00128	0.00254	CcSEcCtD
Metyrosine—Anaemia—Methotrexate—urinary bladder cancer	0.00127	0.00252	CcSEcCtD
Metyrosine—TH—Metabolism—RRM2—urinary bladder cancer	0.00125	0.00277	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—TP53—urinary bladder cancer	0.00124	0.00275	CbGpPWpGaD
Metyrosine—Nausea—Cisplatin—urinary bladder cancer	0.00121	0.00241	CcSEcCtD
Metyrosine—Vomiting—Etoposide—urinary bladder cancer	0.00119	0.00236	CcSEcCtD
Metyrosine—Anaemia—Epirubicin—urinary bladder cancer	0.00118	0.00236	CcSEcCtD
Metyrosine—Headache—Etoposide—urinary bladder cancer	0.00117	0.00233	CcSEcCtD
Metyrosine—TH—Metabolism—ENO2—urinary bladder cancer	0.00116	0.00257	CbGpPWpGaD
Metyrosine—TH—Metabolism—HPGDS—urinary bladder cancer	0.00116	0.00257	CbGpPWpGaD
Metyrosine—Confusional state—Methotrexate—urinary bladder cancer	0.00113	0.00224	CcSEcCtD
Metyrosine—TH—Metabolism—GSTT1—urinary bladder cancer	0.00112	0.00249	CbGpPWpGaD
Metyrosine—Nausea—Etoposide—urinary bladder cancer	0.00111	0.00221	CcSEcCtD
Metyrosine—Anaemia—Doxorubicin—urinary bladder cancer	0.0011	0.00218	CcSEcCtD
Metyrosine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00109	0.00218	CcSEcCtD
Metyrosine—Anxiety—Epirubicin—urinary bladder cancer	0.00109	0.00217	CcSEcCtD
Metyrosine—Dry mouth—Epirubicin—urinary bladder cancer	0.00107	0.00213	CcSEcCtD
Metyrosine—Confusional state—Epirubicin—urinary bladder cancer	0.00106	0.0021	CcSEcCtD
Metyrosine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00102	0.00204	CcSEcCtD
Metyrosine—Insomnia—Methotrexate—urinary bladder cancer	0.00101	0.00201	CcSEcCtD
Metyrosine—Anxiety—Doxorubicin—urinary bladder cancer	0.00101	0.002	CcSEcCtD
Metyrosine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000988	0.00197	CcSEcCtD
Metyrosine—Confusional state—Doxorubicin—urinary bladder cancer	0.000976	0.00194	CcSEcCtD
Metyrosine—Fatigue—Methotrexate—urinary bladder cancer	0.000964	0.00192	CcSEcCtD
Metyrosine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000948	0.00189	CcSEcCtD
Metyrosine—Insomnia—Epirubicin—urinary bladder cancer	0.000946	0.00188	CcSEcCtD
Metyrosine—TH—Metabolism—NQO1—urinary bladder cancer	0.000932	0.00207	CbGpPWpGaD
Metyrosine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000921	0.00183	CcSEcCtD
Metyrosine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000914	0.00182	CcSEcCtD
Metyrosine—Fatigue—Epirubicin—urinary bladder cancer	0.000902	0.0018	CcSEcCtD
Metyrosine—Urticaria—Methotrexate—urinary bladder cancer	0.000888	0.00177	CcSEcCtD
Metyrosine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000884	0.00176	CcSEcCtD
Metyrosine—Insomnia—Doxorubicin—urinary bladder cancer	0.000876	0.00174	CcSEcCtD
Metyrosine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000862	0.00172	CcSEcCtD
Metyrosine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000856	0.0017	CcSEcCtD
Metyrosine—Fatigue—Doxorubicin—urinary bladder cancer	0.000835	0.00166	CcSEcCtD
Metyrosine—Urticaria—Epirubicin—urinary bladder cancer	0.000831	0.00165	CcSEcCtD
Metyrosine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000827	0.00165	CcSEcCtD
Metyrosine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000824	0.00164	CcSEcCtD
Metyrosine—Asthenia—Methotrexate—urinary bladder cancer	0.000802	0.0016	CcSEcCtD
Metyrosine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000798	0.00159	CcSEcCtD
Metyrosine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000792	0.00158	CcSEcCtD
Metyrosine—TH—Metabolism—GSTP1—urinary bladder cancer	0.000778	0.00172	CbGpPWpGaD
Metyrosine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000771	0.00153	CcSEcCtD
Metyrosine—Urticaria—Doxorubicin—urinary bladder cancer	0.000769	0.00153	CcSEcCtD
Metyrosine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000765	0.00152	CcSEcCtD
Metyrosine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000765	0.00152	CcSEcCtD
Metyrosine—Asthenia—Epirubicin—urinary bladder cancer	0.000751	0.00149	CcSEcCtD
Metyrosine—TH—Metabolism—TYMS—urinary bladder cancer	0.000723	0.0016	CbGpPWpGaD
Metyrosine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000716	0.00143	CcSEcCtD
Metyrosine—TH—Metabolism—GSTM1—urinary bladder cancer	0.000714	0.00158	CbGpPWpGaD
Metyrosine—TH—Metabolism—NCOR1—urinary bladder cancer	0.000714	0.00158	CbGpPWpGaD
Metyrosine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000713	0.00142	CcSEcCtD
Metyrosine—Vomiting—Methotrexate—urinary bladder cancer	0.000711	0.00142	CcSEcCtD
Metyrosine—Headache—Methotrexate—urinary bladder cancer	0.0007	0.00139	CcSEcCtD
Metyrosine—Asthenia—Doxorubicin—urinary bladder cancer	0.000695	0.00138	CcSEcCtD
Metyrosine—TH—Metabolism—GPX1—urinary bladder cancer	0.000684	0.00152	CbGpPWpGaD
Metyrosine—TH—Metabolism—ERCC2—urinary bladder cancer	0.000672	0.00149	CbGpPWpGaD
Metyrosine—Vomiting—Epirubicin—urinary bladder cancer	0.000665	0.00132	CcSEcCtD
Metyrosine—Nausea—Methotrexate—urinary bladder cancer	0.000664	0.00132	CcSEcCtD
Metyrosine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000662	0.00132	CcSEcCtD
Metyrosine—Headache—Epirubicin—urinary bladder cancer	0.000656	0.0013	CcSEcCtD
Metyrosine—TH—Metabolism—MTHFR—urinary bladder cancer	0.000631	0.0014	CbGpPWpGaD
Metyrosine—Nausea—Epirubicin—urinary bladder cancer	0.000622	0.00124	CcSEcCtD
Metyrosine—Vomiting—Doxorubicin—urinary bladder cancer	0.000616	0.00123	CcSEcCtD
Metyrosine—Headache—Doxorubicin—urinary bladder cancer	0.000607	0.00121	CcSEcCtD
Metyrosine—Nausea—Doxorubicin—urinary bladder cancer	0.000575	0.00114	CcSEcCtD
Metyrosine—TH—Metabolism—PPARG—urinary bladder cancer	0.000512	0.00114	CbGpPWpGaD
Metyrosine—TH—Metabolism—CREBBP—urinary bladder cancer	0.000492	0.00109	CbGpPWpGaD
Metyrosine—TH—Metabolism—PTGS2—urinary bladder cancer	0.000403	0.000894	CbGpPWpGaD
Metyrosine—TH—Metabolism—PTEN—urinary bladder cancer	0.000351	0.000779	CbGpPWpGaD
Metyrosine—TH—Metabolism—EP300—urinary bladder cancer	0.000335	0.000743	CbGpPWpGaD
